These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30721874)

  • 1. Switching from traditional sodium channel blockers to lacosamide in patients with epilepsy.
    Kim DW; Kim HK; Bae EK
    Seizure; 2019 Feb; 65():172-175. PubMed ID: 30721874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of lacosamide in children and young adults previously treated with other sodium channel blockers.
    Suzuki T; Natsume J; Kumai S; Maki Y; Yamamoto H; Numoto S; Narahara S; Kubota T; Tsuji T; Kato T; Yamada K; Maruyama K; Okumura A; Takahashi Y; Kidokoro H
    Epilepsy Behav; 2021 Dec; 125():108397. PubMed ID: 34814035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lacosamide use in children with epilepsy: Retention rate and effect of concomitant sodium channel blockers in a large cohort.
    McGinnis E; Kessler SK
    Epilepsia; 2016 Sep; 57(9):1416-25. PubMed ID: 27430392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide.
    Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C
    Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy.
    Baulac M; Byrnes W; Williams P; Borghs S; Webster E; De Backer M; Dedeken P
    Acta Neurol Scand; 2017 Apr; 135(4):434-441. PubMed ID: 27714769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience combined with therapeutic drug monitoring of lacosamide.
    Svendsen T; Brodtkorb E; Baftiu A; Lossius MI; Nakken KO; Johannessen SI; Johannessen Landmark C
    Acta Neurol Scand; 2020 Apr; 141(4):279-286. PubMed ID: 31853958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lacosamide in the treatment of patients with epilepsy and intellectual disabilities: A long-term study of 136 patients.
    Böttcher S; Lutz MT; Mayer T
    Epilepsia; 2017 Oct; 58(10):1749-1754. PubMed ID: 28804872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium channel blockers are effective for benign infantile epilepsy.
    Numoto S; Kurahashi H; Takagi M; Azuma Y; Iwayama H; Okumura A
    Seizure; 2021 Nov; 92():207-210. PubMed ID: 34592700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lacosamide in patients with intellectual disability and refractory epilepsy.
    Kleist A; Kerling F; Hamer H; Winterholler M
    Acta Neurol Belg; 2019 Sep; 119(3):423-430. PubMed ID: 30840220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Monitoring of Lacosamide in Japanese Patients With Epilepsy: Clinical Response, Tolerability, and Optimal Therapeutic Range.
    Yamamoto Y; Terada K; Araki Y; Fukushima Y; Imai K; Kagawa Y; Takahashi Y
    Ther Drug Monit; 2020 Oct; 42(5):754-759. PubMed ID: 32941398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational polytherapy with lacosamide in clinical practice: results of a Spanish cohort analysis RELACOVA.
    Villanueva V; López-Gomáriz E; López-Trigo J; Palau J; García M; Villarroya T; Bonet M; Santafé C
    Epilepsy Behav; 2012 Mar; 23(3):298-304. PubMed ID: 22370116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lacosamide for SCN2A-related intractable neonatal and infantile seizures.
    Flor-Hirsch H; Heyman E; Livneh A; Reish O; Watemberg N; Litmanovits I; Ben Sason Lilli A; Lev D; Lerman Sagie T; Bassan H
    Epileptic Disord; 2018 Oct; 20(5):440-446. PubMed ID: 30361185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
    Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
    Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with using lacosamide for the treatment of epilepsy in a tertiary centre.
    Kamel JT; DeGruyter MA; D'Souza WJ; Cook MJ
    Acta Neurol Scand; 2013 Mar; 127(3):149-53. PubMed ID: 22845761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
    Rosati A; Ilvento L; Rizzi R; Doccini V; Leo MC; Pugi A; De Masi S; Guerrini R
    Epilepsia; 2018 May; 59(5):1004-1010. PubMed ID: 29663335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium channel blockers for the treatment of epilepsy in CDKL5 deficiency disorder: Findings from a multicenter cohort.
    Aledo-Serrano Á; Gómez-Iglesias P; Toledano R; Garcia-Peñas JJ; Garcia-Morales I; Anciones C; Soto-Insuga V; Benke TA; Del Pino I; Gil-Nagel A
    Epilepsy Behav; 2021 May; 118():107946. PubMed ID: 33848848
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Li Y; Guo HL; Wang J; Zhang YY; Wang WJ; Huang J; Fan L; Hu YH; Lu XP; Chen F
    Ther Adv Neurol Disord; 2024; 17():17562864241273087. PubMed ID: 39314259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching carbamazepine to lacosamide improves gamma-glutamyl transpeptidase levels.
    Kubota Y; Prado M
    Epilepsia Open; 2024 Oct; 9(5):1956-1961. PubMed ID: 39141546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the efficacy and influencing factors of sodium channel blockers in the treatment of focal epilepsy in infants under 6 months of age].
    Ma YP; Deng J; Fu ZR; Chen CH; Wang XH; Wang X; Weng JW; Shen YH
    Zhonghua Er Ke Za Zhi; 2023 Nov; 61(11):983-988. PubMed ID: 37899337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.